New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement (2020)
- Authors:
- USP affiliated authors: FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.3389/978-2-88963-472-9
- Subjects: AUTOIMUNIDADE; CÉLULAS VEGETAIS; TRANSPLANTE DE ÓRGÃOS; BIOMARCADORES; DIABETES MELLITUS; TRANSPLANTE AUTÓLOGO; IMUNOSSUPRESSÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Frontiers Media
- Publisher place: Lausanne
- Date published: 2020
- Source:
- Título: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Volume/Número/Paginação/Ano: 133 p
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
COURI, Carlos Eduardo Barra e FARIAS, Kelen Cristina Ribeiro Malmegrim de e RODRIGUES, Maria Carolina de Oliveira. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 21 out. 2024. -
APA
Couri, C. E. B., Farias, K. C. R. M. de, & Rodrigues, M. C. de O. (2020). New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9 -
NLM
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 out. 21 ] Available from: https://doi.org/10.3389/978-2-88963-472-9 -
Vancouver
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 out. 21 ] Available from: https://doi.org/10.3389/978-2-88963-472-9 - Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Teplizumab in relatives at risk for type 1 diabetes. [Carta]
- Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II
- Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers
- CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]
- Thymus rejuvenation after autologous hematopoietic stem cell transplantation in patients with autoimmune diseases
- Transplante de células-tronco hematopoéticas para doenças auto-imunes graves e refratárias ao tratamento convencional
Informações sobre o DOI: 10.3389/978-2-88963-472-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas